127 related articles for article (PubMed ID: 32220488)
1. Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study.
Pargaonkar VS; Tremmel JA; Schnittger I; Khandelwal A
Int J Cardiol; 2020 Jun; 309():8-13. PubMed ID: 32220488
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of non-invasive stress testing in women and men with angina in the absence of obstructive coronary artery disease.
Pargaonkar VS; Kobayashi Y; Kimura T; Schnittger I; Chow EKH; Froelicher VF; Rogers IS; Lee DP; Fearon WF; Yeung AC; Stefanick ML; Tremmel JA
Int J Cardiol; 2019 May; 282():7-15. PubMed ID: 30527992
[TBL] [Abstract][Full Text] [Related]
4. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
Rambarat CA; Elgendy IY; Handberg EM; Bairey Merz CN; Wei J; Minissian MB; Nelson MD; Thomson LEJ; Berman DS; Shaw LJ; Cook-Wiens G; Pepine CJ
Int J Cardiol; 2019 Feb; 276():8-13. PubMed ID: 30293664
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
6. Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis: The MARINA Randomized, Double-Blinded, Controlled Pilot Trial.
Koh JS; Hung OY; Eshtehardi P; Kumar A; Rabah R; Raad M; Kumar S; Chaudhry S; Gupta S; Hosseini H; Brilakis E; Corban M; Sabbak N; Burnett GM; Liu C; Mehta PK; Quyyumi AA; Samady H
Circ Cardiovasc Interv; 2020 Dec; 13(12):e008204. PubMed ID: 33272036
[TBL] [Abstract][Full Text] [Related]
7. Ranolazine for Symptomatic Management of Microvascular Angina.
Rayner-Hartley E; Parvand M; Humphries KH; Starovoytov A; Park JE; Sedlak T
Am J Ther; 2020; 27(2):e151-e158. PubMed ID: 29746286
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
[TBL] [Abstract][Full Text] [Related]
9. Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
Ahmed B; Mondragon J; Sheldon M; Clegg S
Cardiovasc Revasc Med; 2017 Sep; 18(6):431-435. PubMed ID: 28576663
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction-A Systematic Review and Meta-analysis of Randomized Trials.
Kofler T; Hess S; Moccetti F; Pepine CJ; Attinger A; Wolfrum M; Toggweiler S; Kobza R; Cuculi F; Bossard M
CJC Open; 2021 Jan; 3(1):101-108. PubMed ID: 33458636
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.
Mehta PK; Sharma S; Minissian M; Harsch MR; Martinson M; Nyman JA; Shaw LJ; Bairey Merz CN; Wenger NK
J Womens Health (Larchmt); 2019 May; 28(5):573-582. PubMed ID: 30888919
[No Abstract] [Full Text] [Related]
12. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
13. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
[TBL] [Abstract][Full Text] [Related]
14. Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
Suppogu N; Wei J; Quesada O; Shufelt C; Cook-Wiens G; Samuels B; Petersen JW; Anderson RD; Handberg EM; Pepine CJ; Bairey Merz CN
Int J Cardiol; 2021 Jun; 333():35-39. PubMed ID: 33662486
[TBL] [Abstract][Full Text] [Related]
15. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
Mark DB; Spertus JA; Bigelow R; Anderson S; Daniels MR; Anstrom KJ; Baloch KN; Cohen DJ; Held C; Goodman SG; Bangalore S; Cyr D; Reynolds HR; Alexander KP; Rosenberg Y; Stone GW; Maron DJ; Hochman JS;
Circulation; 2022 Apr; 145(17):1294-1307. PubMed ID: 35259918
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ranolazine in Patients with Chest Pain and Normal Coronaries- A Hospital Based Study.
Saha S; Ete T; Kapoor M; Jha PK; Megeji RD; Kavi G; Warjri SB; Mishra A
J Clin Diagn Res; 2017 Apr; 11(4):OC14-OC16. PubMed ID: 28571183
[TBL] [Abstract][Full Text] [Related]
18. Depression and chest pain in patients with coronary artery disease.
Hayek SS; Ko YA; Awad M; Del Mar Soto A; Ahmed H; Patel K; Yuan M; Maddox S; Gray B; Hajjari J; Sperling L; Shah A; Vaccarino V; Quyyumi AA
Int J Cardiol; 2017 Mar; 230():420-426. PubMed ID: 28041701
[TBL] [Abstract][Full Text] [Related]
19. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease.
Lee BK; Lim HS; Fearon WF; Yong AS; Yamada R; Tanaka S; Lee DP; Yeung AC; Tremmel JA
Circulation; 2015 Mar; 131(12):1054-60. PubMed ID: 25712205
[TBL] [Abstract][Full Text] [Related]
20. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
